http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-104934-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ac40e7aead52a7105c7cb0309cf4668 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2000-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d910818e1abd8930b03543526d51ca |
| publicationDate | 2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-104934-A |
| titleOfInvention | MEDICINAL MEDICINE FOR TREATMENT OF ISCHEMICAL BRAIN INSERT / |
| abstract | The drug contains the following compounds in mg: sodium salicylicum from 1000.00 to 2000.00, adenosine triphosphate (phosphonium) from 10.00 to 20.00; vitamin B12 (cyanocobalaminum) of 1000.00 to 6000.00 and procaine (novocaine) from 20.00 to 100.00. The agent is dissolved in double distilled water up to 20 ml to stabilize the aqueous solution, especially novacaine, to which 0.1 n HCl is added until a pH of 3.8-4.5 is reached. |
| priorityDate | 2000-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.